Wix.com Ltd. (WIX)

Software / Creación web / IA

Wix converts 304.2 million registered users into subscriptions that are mostly annual and prepaid. The market discounts the risk that generative AI makes its product unnecessary just as the Base44 bet compressed the cash margin; at $77 the base case returns +26% annually (Very undervalued).

Moat Compounder estimates the intrinsic value of Wix.com Ltd. (WIX) at $240 per share on a five-year horizon. With the stock at $76.80 at 2026-09-23 close, the expected total return is 25.6% per year: very undervalued. The analysis draws on 20-F 2025 (fiscal year ended December 31, 2025) and 6-K second-quarter 2026 results (period ended June 30, 2026). Analysis dated 2026-08-04.

Price
$76.80
at 2026-09-23 close
Intrinsic value (5y, base)
$240
Total annual return (5y)
25.6%
Status (nominal)
Very undervalued
Margin of safety
+60%

The essentials

  • Second-quarter 2026 revenue of $563.1M (+15% year over year) and total ARR of $1,963M (+15%), above the 12.5%-13.2% band of the last three fiscal years, driven in part by Base44 (acquired in June 2025, still without a comparable base) and with full-year guidance cut in June to growth in the low-to-mid part of the 10%-19% range.
  • The valuation metric expenses stock-based compensation: reported trailing-twelve-month free cash flow ($410.5M) is left at ~$183M net of it.
  • The company bought back ~29.7% of its shares at $92.00 in April 2026, funded with cash, sale of securities and a $500M credit facility.
  • The base case assumes the cash margin net of stock-based compensation returns to ~15% by year 5 (17.3% in 2025, operating cash flow net of stock-based compensation) as Base44 matures; the adverse scenario leaves it at 9%.
Health: Fragile
Price $77 at 2026-09-23 closeMarket Cap $3.3 bnEnterprise Value $4 bnNet debt $0.7 bnEV/FCF maintenance (today) 21.1x

Intrinsic value — two valuation methods

Margin of safety
Price market
$77
DCF value today
$212
+176.5% vs price
Multiples value today
$193
+150.8% vs price

By both methods, the value today (DCF $212 · Multiples $193) exceeds the market price ($77).

Pillars of the analysis

The verdict — today vs 5 years

Today — with margin of safety: at $77 trades ~60.1% below its value discounted to today (~$193) — the wide discount we require (≥38%, equivalent to a ~15% annual return); the risk is covered by the margin, not the rate.

At 5 years — Muy infravalorado: the target price ($240) plus dividends yield above the required average return (10%) — the business compounds.

The bridge: the return at 5 years comfortably exceeds the risk-free rate (4.5%) — and the discount reaches the required margin of safety.

Thesis

The business

A prepaid subscription business with sustained double-digit growth (12.5% · 12.7% · 13.2% over the last three fiscal years and +15% in the second quarter of 2026) and minimal capex. Accounting quality is distorted over the trailing twelve months by Base44 acquisition expenses and restructuring; operating cash flow net of stock-based compensation was 17.3% of revenue in 2025 (net free cash flow: 16.8%). On June 8, 2026 the company announced a reorganization cutting ~20% of headcount (~1,000 employees) due to the Partners slowdown, with an estimated ~$150M in annual recurring savings against $30-35M in restructuring charges.

The valuation

Valued on the multiple of the maintenance flow net of stock-based compensation, within the enterprise software archetype band. With revenue growth decelerating from 12% to 8.5% and a cash margin recovering to ~15%, the base case's 5-year value is $240 per share, a return of +26% annually against $77. The entry multiple is 21× today and 8× in 5 years on the base case metric.

The margin of safety

There is a margin of safety: the market's perception is meaningfully worse than reality. The adverse scenario — revenue decelerating to 2% and the cash margin stuck at 9% because stock-based compensation does not compress — returns +26% annually; the favorable one, +26%. The price required for a 15% annual return leaves a margin of +36%.

What to watch

The disconfirming test is Base44's margin curve: if the adjusted (non-GAAP) gross margin does not reach the ~60% the company anticipates for the second half of 2026, or if core-business revenue growth fades in the face of AI tools, the cash margin recovery does not happen. Second focus: compliance with the bank debt covenant on free cash flow (≤2.0×) and the refinancing of the $500M credit facility.

Educational / informational. Does not constitute investment advice.

Other companies of the same type